159 related articles for article (PubMed ID: 22517186)
41. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time.
Weitz J; Antonescu CR; Brennan MF
J Clin Oncol; 2003 Jul; 21(14):2719-25. PubMed ID: 12860950
[TBL] [Abstract][Full Text] [Related]
42. Surgical management of soft tissue sarcomas of the hand and foot.
Lin PP; Guzel VB; Pisters PW; Zagars GK; Weber KL; Feig BW; Pollock RE; Yasko AW
Cancer; 2002 Aug; 95(4):852-61. PubMed ID: 12209730
[TBL] [Abstract][Full Text] [Related]
43. Leiomyosarcoma: a 45-year review at Charity Hospital, New Orleans.
Hill MA; Mera R; Levine EA
Am Surg; 1998 Jan; 64(1):53-60; discussion 60-1. PubMed ID: 9457038
[TBL] [Abstract][Full Text] [Related]
44. The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study.
Akhan SE; Yavuz E; Tecer A; Iyibozkurt CA; Topuz S; Tuzlali S; Bengisu E; Berkman S
Gynecol Oncol; 2005 Oct; 99(1):36-42. PubMed ID: 15992918
[TBL] [Abstract][Full Text] [Related]
45. Risk factors for local recurrence and metastasis in soft tissue sarcomas of the extremity.
Sabolch A; Feng M; Griffith K; Rzasa C; Gadzala L; Feng F; Biermann JS; Chugh R; Ray M; Ben-Josef E
Am J Clin Oncol; 2012 Apr; 35(2):151-7. PubMed ID: 21336091
[TBL] [Abstract][Full Text] [Related]
46. Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma.
Kushner DM; Webster KD; Belinson JL; Rybicki LA; Kennedy AW; Markman M
Gynecol Oncol; 2000 Aug; 78(2):221-7. PubMed ID: 10926807
[TBL] [Abstract][Full Text] [Related]
47. The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high-volume referral centers.
Zagami P; Comandone A; Fiore M; Baldi GG; Grignani G; Vincenzi B; Gronchi A; Antonarelli G; Boglione A; Pennacchioli E; Curigliano G; Conforti F; De Pas TM
Cancer Med; 2023 Aug; 12(16):17047-17055. PubMed ID: 37455549
[TBL] [Abstract][Full Text] [Related]
48. Recurrence patterns of retroperitoneal leiomyosarcoma and impact of salvage surgery.
Ikoma N; Torres KE; Lin HY; Ravi V; Roland CL; Mann GN; Hunt KK; Cormier JN; Feig BW
J Surg Oncol; 2017 Sep; 116(3):313-319. PubMed ID: 28557016
[TBL] [Abstract][Full Text] [Related]
49. Primary cutaneous and subcutaneous leiomyosarcomas: evolution and prognostic factors.
Aneiros-Fernandez J; Antonio Retamero J; Husein-Elahmed H; Ovalle F; Aneiros-Cachaza J
Eur J Dermatol; 2016; 26(1):9-12. PubMed ID: 26678649
[TBL] [Abstract][Full Text] [Related]
50. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison.
Clary BM; DeMatteo RP; Lewis JJ; Leung D; Brennan MF
Ann Surg Oncol; 2001 May; 8(4):290-9. PubMed ID: 11352301
[TBL] [Abstract][Full Text] [Related]
51. Gene expression profiling in leiomyosarcomas and undifferentiated pleomorphic sarcomas: SRC as a new diagnostic marker.
Villacis RA; Silveira SM; Barros-Filho MC; Marchi FA; Domingues MA; Scapulatempo-Neto C; Aguiar S; Lopes A; Cunha IW; Rogatto SR
PLoS One; 2014; 9(7):e102281. PubMed ID: 25028927
[TBL] [Abstract][Full Text] [Related]
52. A closer look at the natural history and recurrence patterns of high-grade truncal/extremity leiomyosarcomas: A multi-institutional analysis from the US Sarcoma Collaborative.
Lee RM; Ethun CG; Zaidi MY; Tran TB; Poultsides GA; Grignol VP; Howard JH; Bedi M; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Oskouei SV; Monson DK; Reimer NB; Maithel SK; Cardona K
Surg Oncol; 2020 Sep; 34():292-297. PubMed ID: 32891345
[TBL] [Abstract][Full Text] [Related]
53. Leiomyosarcoma: Prognostic outline of a rare head and neck malignancy.
Saluja TS; Iyer J; Singh SK
Oral Oncol; 2019 Aug; 95():100-105. PubMed ID: 31345375
[TBL] [Abstract][Full Text] [Related]
54. Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma.
Lamm W; Natter C; Schur S; Köstler WJ; Reinthaller A; Krainer M; Grimm C; Horvath R; Amann G; Funovics P; Brodowicz T; Polterauer S
BMC Cancer; 2014 Dec; 14():981. PubMed ID: 25523155
[TBL] [Abstract][Full Text] [Related]
55. Leiomyosarcoma of the urinary bladder: A SEER database study and comparison to leiomyosarcomas of the uterus and extremities/trunk.
Coiner BL; Cates J; Kamanda S; Giannico GA; Gordetsky JB
Ann Diagn Pathol; 2021 Aug; 53():151743. PubMed ID: 33964611
[TBL] [Abstract][Full Text] [Related]
56. Optimal surgical treatment for paratesticular leiomyosarcoma: retrospective analysis of 217 reported cases.
Kamitani R; Matsumoto K; Takeda T; Mizuno R; Oya M
BMC Cancer; 2022 Jan; 22(1):15. PubMed ID: 34980039
[TBL] [Abstract][Full Text] [Related]
57. Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma.
Roland CL; Boland GM; Demicco EG; Lusby K; Ingram D; May CD; Kivlin CM; Watson K; Al Sannaa GA; Wang WL; Ravi V; Pollock RE; Lev D; Cormier JN; Hunt KK; Feig BW; Lazar AJ; Torres KE
JAMA Surg; 2016 Apr; 151(4):347-54. PubMed ID: 26629783
[TBL] [Abstract][Full Text] [Related]
58. Clinical outcome of leiomyosarcomas of vascular origin: comparison with leiomyosarcomas of other origin.
Italiano A; Toulmonde M; Stoeckle E; Kind M; Kantor G; Coindre JM; Bui B
Ann Oncol; 2010 Sep; 21(9):1915-1921. PubMed ID: 20167595
[TBL] [Abstract][Full Text] [Related]
59. Treatment outcome of superficial leiomyosarcoma.
Wellings EP; Tibbo ME; Rose PS; Folpe AL; Houdek MT
J Surg Oncol; 2021 Jan; 123(1):127-132. PubMed ID: 33063336
[TBL] [Abstract][Full Text] [Related]
60. The prognostic value of tumor-associated macrophages in leiomyosarcoma: a single institution study.
Ganjoo KN; Witten D; Patel M; Espinosa I; La T; Tibshirani R; van de Rijn M; Jacobs C; West RB
Am J Clin Oncol; 2011 Feb; 34(1):82-6. PubMed ID: 23781555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
